Ameliorative effect of butylated hydroxyanisole against ferric nitrilotriacetate-induced hepatotoxicity and oxidative stress in rats

Abstract

Ferric nitrilotriacetate (Fe-NTA) is a known renal carcinogen and has been shown to adversely induce oxidative stress and tissue toxicity after both acute and chronic exposure. Present studies were designed to study the hepatoprotective and antioxidant potential of butylated hydroxyanisole (BHA), a phenolic antioxidant used in foods on ferric nitrilotriacetate (Fe-NTA) induced hepatotoxicity in rats. Male albino rats of Wistar strain (4–6 weeks old) weighing 125–150 g were used in this study. Animals were given a single dose of Fe-NTA (9 mg/kg body weight, intraperitoneal) after a week’s treatment with BHA. BHA was administered orally once daily for 7 days at doses of 1 and 2 mg/animal/day. The hepatoprotective activity was assessed using various biochemical parameters as serum transaminases (alanine transaminase (ALT), aspartate transaminase (AST)) and lactate dehydrogenase (LDH). Fe-NTA treatment increased ALT, AST, and LDH levels significantly when compared to the corresponding saline-treated group (p < 0.001). Fe-NTA also depleted the levels of glutathione and the activities of antioxidant enzymes namely glutathione reductase and glutathione-S-tranferase (p < 0.05). Pretreatment with BHA significantly decreased ALT, AST and LDH levels in a dose-dependent manner (p < 0.05). BHA also increased antioxidant enzymes level and decreased lipid peroxidation and hydrogen peroxide generation to 1.3–1.5-fold as compared to Fe-NTA-treated group. The results show the strong hepatoprotective activity of BHA which could be due to its potent antioxidant effects.

Keywords

Acute toxicity animal model cancer liver renal

Get full access to this article

View all access options for this article.

References

Ansar

Iqbal

Athar

(1999) Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumor promotion in mice. Carcinogenesis 20: 599–606.

Athar

Iqbal

(1998) Ferric-nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumerigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis 19: 1133–1139.

Awai

Narasaki

Yamanoi

. (1979) Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. American Journal of Pathology 95: 663–667.

Buetler

(1995) Induction of phase 1 and phase 11 drug metabolizing enzyme mRNA protein and activity by BHA, ethoxyquin and oltipraz. Toxicology and Applied Pharmacology 135: 45–57.

Cai

Tsiapalis

Cherian

(1998) Protective role of zinc-metallothionin on DNA damage in vitro by ferric nitrilotiracetate (Fe-NTA) and ferric salts. Chemico-Biological Interactions 115: 141–151.

Carlberg

Mannervik

(1975) Glutathione reductase levels in rat brain. Journal of Biological Chemistry 250: 5475–5480.

Chung

(1999) Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylaiton of 2-aminoflourine and DNA-2-aminoflourene adducts in the rats. Toxicological Science 51: 202–210.

Habig

Pabst

Jokoby

(1974) Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249: 7130–7139.

Hirose

(1999) Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food and Chemical Toxicology 37: 985–992.

10.

Hirose

Takahashi

Ogawa

. (1999) Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats. Cancer Letters 143: 173–178.

11.

Iqbal

Athar

(1998) Attenuation of iron-nitrilotriacetate (Fe-NTA)-mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Food and Chemical Toxicology 36: 485–495.

12.

Iqbal

Giri

Athar

(1995) Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochemical and Biophysical Research Communications 212: 557–563.

13.

Iqbal

Rezazadeh

Ansar

. (1998) Alpha-tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress. Human and Experimental Toxicology 17: 163–171.

14.

Iqbal

Sharma

Rezazadeh

. (1996) Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate (Fe-NTA) mediated hepatic injury. Redox Report 2: 385–391.

15.

Iverson

(1995) Phenolic antioxidants: health protection branch studies on butylated hydroxyanisole. Cancer Letters 93: 49–54.

16.

Jollow

Mitchell

Zampaglione

. (1974) Bromobenzen induce liver necrosis protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 11: 151–169.

17.

Khan

Sharma

Alam

. (2001) Tephrosia purpurea ameliorates N-diethylnitrosamine and potassium bromate-mediated renal oxidative stress and toxicity in Wistar rats. Pharmacology and Toxicology 88: 294–299.

18.

Khan

Sharma

Sultana

(2003) Nigella sativa ameliorates potassium bromate induced early events of carcinogenesis: diminution of oxidative stress. Human Experimental Toxicology 22: 193–203.

19.

Khan

Sharma

Sultana

(2004) Coumarin is a potent chemopreventive agent and suppresses Fe-NTA induced nephrotoxicity in Wistar rats. Cancer Letters 210: 17–26.

20.

Levine

Garland

Oliver

(1990) Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186: 464–478.

21.

Mohandas

Marshall

Duggin

. (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible implications in analgesic neuropathy. Cancer Research 44: 5086–5091.

22.

Pick

Keisari

(1981) Superoxide anion and H₂O₂ production by chemically elicited Peritoneal macrophages-induction by multiple nonphagocytic stimulus. Cell Immunology 59: 301–308.

23.

Reitman

Frankel

(1957) Colorimetric method for determination of glutamic oxaloacetic and glutamic pyruvic transminase. American Journal Clinical Pathology 28: 56–63.

24.

Slaga

(1995a) Inhibition of skin tumor initiation, promotion and progression by antioxidants and related compounds. Critical Review Food Science Nutrition 35: 51–57.

25.

Slaga

(1995b) Inhibition of the induction of cancer by antioxidants. Advances in Experimental Medicine and Biology 369: 167–174.

26.

Soni

(1997) Protective effect of food additives on aflatoxin-induced mutagenecity and herpatocarcinogenecity. Cancer Letters 115: 129–133.

27.

Toyokuni

Mori

Hiai

. (1995) Treatment of Wistar rats with renal carcinogen, ferric nitrilotriacetate causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. International Journal of Cancer 62: 309–313.

28.

Toyokuni

Okada

Kondo

. (1998) Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Japanese Journal of Cancer Research 89: 814–820.

29.

Wattenberg

(1992a) Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg

Lipkin

Boone

Kelloff

(eds) Cancer Chemoprevention. Ann Arbor: CRC Press, pp. 19–39.

30.

Wattenberg

(1992b) Inhibition of carcinogenesis by minor dietary constituents. Cancer Research 52: 2085–2089.

31.

Williams

(1999) Safety assessments of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food adjectives. Food and Chemical Toxicology 37: 1027–1038.

32.

Wright

Colby

Miles

(1981) Cytosolic factors which affect microsomal LPO in lung and liver. Archives of Biochemistry and Biophysics 206: 296–304.

33.

Wroblewski

La Due

(1995) Lactic dehydrogenase activity in blood. Proceedings of the Society of Experimental Biology and Medicine 90: 210–213.

34.

Zhao

Khan

O’Brien

(1997) The prevention of ferric nitrilotriacetae-induced nephro and hepatotoxicity by methylenedioxybenzene antioxidants. Proceedings of National Academy of Science 70: 1461–1467.